MONICA MAIS: Open Payments
NPI 1902233349 · YREKA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$168 in 7 payments from 5 companies in 2025. Trend: 2023 $21 · 2024 $234 · 2025 $168
Food & beverage: $168
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 2 | $65 |
| Novo Nordisk Inc | 2 | $51 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $22 |
| ABBVIE INC. | 1 | $16 |
| Otsuka America Pharmaceutical, Inc. | 1 | $15 |
Products named: Wegovy, MOUNJARO, Kerendia, Ozempic, MAVYRET, REXULTI.
Industry payments across CA — which companies pay providers there.
